Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Isis Earns $1M Merck Milestone | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Isis Earns $1M Merck Milestone

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Merck has initiated clinical development of a compound that was discovered as part of a funded research collaboration between Merck and Isis Pharmaceuticals. Merck will pay Isis a $1 million milestone payment based on the initiation of clinical trials.

Isis’ senior vice president of research, C. Frank Bennett, Ph.D., commented, “We’re pleased to see Merck advancing this molecule in clinical trials. The compound was created out of our productive collaboration, which took advantage of Isis’ expertise in nucleic acid therapeutics. We look forward to Merck’s future progress with this compound.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics